Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$668,013
-$107,289 QoQ
Shares Held
186,596
-15.5% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PDT Partners, LLC holds $78,050,396 across 30 Biotechnology names. RCKT ranks #21 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
145,379 | $13,430,112 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
376,509 | $10,429,299 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
388,338 | $8,388,100 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
473,507 | $4,460,435 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
63,026 | $4,421,273 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
70,048 | $4,392,009 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
265,491 | $3,934,576 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
155,075 | $3,653,567 |
All Filings in RCKT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $668,013 | 186,596 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $775,302 | 220,884 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $867,101 | 265,982 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $651,655 | 265,982 | Shares | Sole | 2025-08-14 | |
| 2022-09-30 | $1,439,863 | 90,217 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,551,151 | 112,729 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,018,592 | 64,224 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||